Hideki Uryu

Minato, 1050003, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 24 publications

Aplastic anemia developed after treatment with durvalumab

Aplastic anemia developed after treatment with durvalumab

Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology

Published: August 30, 2026

Geriatric nutritional risk index for the prediction of venous thrombotic events in multiple myeloma.

Geriatric nutritional risk index for the prediction of venous thrombotic events in multiple myeloma.

Journal: International journal of clinical oncology

Published: April 11, 2026

Treatment and outcomes of pulmonary mucosa-associated lymphoid tissue lymphoma: A multicenter analysis of 186 patients.

Treatment and outcomes of pulmonary mucosa-associated lymphoid tissue lymphoma: A multicenter analysis of 186 patients.

Journal: Cancer

Published: December 23, 2025

Geriatric nutritional risk index predicts 10-year survival in patients with multiple myeloma.

Geriatric nutritional risk index predicts 10-year survival in patients with multiple myeloma.

Journal: Japanese journal of clinical oncology

Published: December 16, 2025

Impact of diagnosis-to-treatment interval in relapsed or refractory diffuse large B-cell lymphoma.

Impact of diagnosis-to-treatment interval in relapsed or refractory diffuse large B-cell lymphoma.

Journal: International journal of hematology

Published: August 09, 2025

Diagnostic challenges in HIV-associated Burkitt lymphoma initially presenting with multifocal neurological symptoms.

Diagnostic challenges in HIV-associated Burkitt lymphoma initially presenting with multifocal neurological symptoms.

Journal: Journal of neurovirology

Published: July 24, 2025

Relative Dose Intensity of Daratumumab, Lenalidomide, and Dexamethasone in Multiple Myeloma.

Relative Dose Intensity of Daratumumab, Lenalidomide, and Dexamethasone in Multiple Myeloma.

Journal: Cancers

Published: November 27, 2024

Second-line anti-CD38 monoclonal antibody therapy mitigates the negative impact of functional high-risk status in myeloma patients.

Second-line anti-CD38 monoclonal antibody therapy mitigates the negative impact of functional high-risk status in myeloma patients.

Journal: International journal of hematology

Published: September 06, 2024

Thrombocytopenia With High C-reactive Protein in Myeloma Patients Treated With Proteasome Inhibitor and/or Immunomodulatory Drugs.

Thrombocytopenia With High C-reactive Protein in Myeloma Patients Treated With Proteasome Inhibitor and/or Immunomodulatory Drugs.

Journal: Cancer diagnosis & prognosis

Published: August 15, 2024

Safety and efficacy of automatic subcutaneous injection of daratumumab via an infusion pump.

Safety and efficacy of automatic subcutaneous injection of daratumumab via an infusion pump.

Journal: International journal of hematology

Published: August 06, 2024

Primary Adrenal Insufficiency Triggered by Cytomegalovirus Infection after Obinutuzumab Plus Bendamustine Therapy for Follicular Lymphoma.

Primary Adrenal Insufficiency Triggered by Cytomegalovirus Infection after Obinutuzumab Plus Bendamustine Therapy for Follicular Lymphoma.

Journal: Internal medicine (Tokyo, Japan)

Published: May 29, 2024

Complex karyotype determined using conventional cytogenetic analysis is a poor prognostic factor in patients with multiple myeloma.

Complex karyotype determined using conventional cytogenetic analysis is a poor prognostic factor in patients with multiple myeloma.

Journal: Journal of clinical and experimental hematopathology : JCEH

Published: March 27, 2024

Showing 1-12 of 24

Last Updated: 09/26/2026